COVID-19 Vaccine Responses in Patients with Autoimmune Disease
The purpose of this study is to evaluate the effectiveness and safety of COVID-19 vaccination in patients with autoimmune disease.
Dr. Alfred Kim
1. Participants must be at least 18 years old
2. Participants must have documented autoimmune disease
3. Participants must not have been previously vaccinated for COVID-19
For more information about this study, contact Volunteer for Health at: